Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...

Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...

Shareholders in Tempus AI, Inc. (NASDAQ:TEM) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The consensus estimated revenue numbers ...

Multiple executives at Tempus AI Inc. TEM executed significant share sales totaling $20.3 million between Feb. 4-7, according to recent Securities and Exchange Commission filings. The transactions ...

Ryan M. Bartolucci, Chief Accounting Officer at Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of company stock, according to a recent SEC filing. On February 5, Bartolucci ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The stock was sold at an average price of $62.50, for a total value of $1.2M.

89.4% of Sabre shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 1.3% of Sabre shares are held by insiders. Strong ...

Erik Phelps, the Executive Vice President and Chief Administrative and Legal Officer of Tempus AI , Inc. (NASDAQ:TEM), recently sold 5,934 shares of Class A Common Stock. The shares were sold at a ...

Tempus AI has a 1 year low of $22.89 and a 1 year high of $79.49. Insider Transactions at Tempus AI In related news, EVP Andrew Polovin sold 51,504 shares of the stock in a transaction that ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday ...